Do equity financing cycles matter? evidence from biotechnology alliances
Material type:
- HD9999 .B443U6Â L476D
Browsing BU Library and Learning Space shelves Close shelf browser (Hides shelf browser)
![]() |
![]() |
No cover image available | No cover image available |
![]() |
![]() |
![]() |
||
HD9999 .B442 āļŠ723āļ GMOs āļ āļēāļĒāđāļāđāļĢāļ°āđāļāļĩāļĒāļāđāļĻāļĢāļĐāļāļāļīāļāļĢāļ°āļŦāļ§āđāļēāļāļāļĢāļ°āđāļāļĻ / | HD9999 .B443E97 E976L Life sciences and biotechnology - a strategy for Europe : communication from the Commission to the European Parliament, the Council, the Economic and Social Committee and the Committee of the Regions / | HD9999 .B443J3 Z824C Capturing technological opportunity via Japan's star scientists : evidence from Japanese firms' biotech patents and products | HD9999 .B443U6 L476D Do equity financing cycles matter? evidence from biotechnology alliances | HD9999 .C67T5 āļĻ169āļ 2547 āļāļļāļĢāļāļīāļāļĻāļ / | HD9999 .C67T5 āļĻ169āļ 2547 āļāļļāļĢāļāļīāļāļĻāļ / | HD9999 .C67T5 āļĻ169āļ 2547 āļāļļāļĢāļāļīāļāļĻāļ / |
There are no comments on this title.